Salk welcomes national leader in academic technology transfer

February 7, 2011

Salk welcomes national leader in academic technology transfer

Strategic Patent, Licensing and Start-Up Visionary Comes to the Salk

February 7, 2011

LA JOLLA, CA—The Salk Institute is pleased to announce the appointment of Robert MacWright, Ph.D., Esq. as Executive Director of the Salk Institute Office of Technology Development. His appointment begins February 14, 2011.

Dr. MacWright has extensive experience in academic technology transfer. For over a decade he was Executive Director of the University of Virginia Patent Foundation, where he led a broad expansion and modernization of its patent and licensing activities. He also led the creation of a subsidiary that supported faculty start-up companies, and the creation of a local angel investment fund. He previously led the creation and development of technology transfer programs at Rutgers University, and served as Executive Director of the Rutgers University Office of Corporate Liaison and Technology Transfer.

“Robert’s strategic and academic experience will be a huge asset to the Salk,” said William R. Brody, President, Salk Institute. “His deep understanding of basic research, academia and industry is unique and he is poised to take our Technology Transfer to new heights.”

Dr. MacWright brings expertise as a patent lawyer, having practiced law at Kenyon & Kenyon, at Skadden, Arps, Slate Meagher & Flom, and at Frommer Lawrence & Haug. He holds a Ph.D. in biochemistry from Rutgers University and the University of Medicine & Dentistry of New Jersey. He has academic and industry research experience in protein chemistry and molecular genetics. He holds a law degree from The Rutgers School of Law in Newark.

“The Office of Technology Management and Development plays a significant role in Salk’s ability to advance basic research into the marketplace. Robert’s energy and advocacy come at a crucial time. We look forward to his leadership,” said Marsha Chandler, Executive Vice President, Salk Institute.

关于索尔克生物研究所：
索尔克生物研究所是世界顶尖的基础研究机构之一，其国际知名的教职人员在一个独特、协作和富有创造性的环境中，深入探究生命科学的基本问题。索尔克科学家们致力于发现和指导未来几代研究人员，通过研究神经科学、遗传学、细胞和植物生物学以及相关学科，在癌症、衰老、阿尔茨海默氏症、糖尿病和传染病的认识方面做出了开创性的贡献。.

学院取得了许多成就，获得了包括诺贝尔奖和美国国家科学院院士在内的无数荣誉。该研究所由脊髓灰质炎疫苗先驱 Jonas Salk 博士于 1960 年创立，是一家独立的非营利组织和建筑地标。.